IDEX Biometrics ASA
IDXAF
$0.20
$0.10100.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 209.00K | 269.00K | 573.00K | 841.00K | 1.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 209.00K | 269.00K | 573.00K | 841.00K | 1.30M |
| Cost of Revenue | 1.34M | 1.36M | 1.53M | 1.68M | 1.61M |
| Gross Profit | -1.13M | -1.09M | -960.00K | -843.00K | -312.00K |
| SG&A Expenses | 3.34M | 4.69M | 6.54M | 8.80M | 9.88M |
| Depreciation & Amortization | 1.82M | 1.31M | 2.27M | 2.52M | 1.61M |
| Other Operating Expenses | 6.51M | 6.73M | 6.88M | 7.29M | 7.09M |
| Total Operating Expenses | 14.27M | 16.39M | 19.63M | 22.74M | 22.59M |
| Operating Income | -14.06M | -16.13M | -19.06M | -21.90M | -21.29M |
| Income Before Tax | -11.09M | -8.74M | -13.29M | -14.57M | -15.63M |
| Income Tax Expenses | -163.00K | -163.00K | -118.00K | -120.00K | 17.00K |
| Earnings from Continuing Operations | -10.93 | -8.57 | -13.17 | -14.45 | -15.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.93M | -8.57M | -13.17M | -14.45M | -15.65M |
| EBIT | -14.06M | -16.13M | -19.06M | -21.90M | -21.29M |
| EBITDA | -13.40M | -15.37M | -17.34M | -20.01M | -19.38M |
| EPS Basic | -1.30 | -0.84 | -3.06 | -4.50 | -5.55 |
| Normalized Basic EPS | -0.53 | -0.24 | -1.63 | -2.82 | -3.47 |
| EPS Diluted | -1.30 | -0.84 | -3.06 | -4.56 | -5.62 |
| Normalized Diluted EPS | -0.53 | -0.24 | -1.63 | -2.82 | -3.46 |
| Average Basic Shares Outstanding | 85.59M | 46.61M | 19.64M | 14.12M | 11.63M |
| Average Diluted Shares Outstanding | 85.59M | 46.63M | 19.66M | 14.14M | 11.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |